Lechi Ye
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Oncology 26
- Colorectal Cancer Treatments and Studies 15
- Colorectal Cancer Surgical Treatments 5
-
- Gastric Cancer Management and Outcomes 6
- Ferroptosis and cancer prognosis 5
- Co-authors
- Ye Wei (15 shared papers)Jianmin Xu (12 shared papers)Dexiang Zhu (14 shared papers)Li Ren (12 shared papers)Xinyu Qin (8 shared papers)Qing‐Hai Ye (5 shared papers)Juji Dai (4 shared papers)Tianshu Liu (5 shared papers)
- Journals
- PLoS ONE (4 papers)Tumor Biology (3 papers)Annals of Surgical Oncology (3 papers)Journal of Clinical Oncology (3 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Lechi Ye
46 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Hepatology 354
- Cancer Research 511
- Oncology 628
- Pulmonary and Respiratory Medicine 396
- Molecular Biology 589
Countries citing papers authored by Lechi Ye
This map shows the geographic impact of Lechi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechi Ye more than expected).
Fields of papers citing papers by Lechi Ye
This network shows the impact of papers produced by Lechi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechi Ye. The network helps show where Lechi Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Lechi Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 296 | |
| 2 | Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer Hit paper breakdown → | 2021 | 225 |
| 3 | 2014 | 193 | |
| 4 | 2012 | 70 | |
| 5 | 2016 | 60 | |
| 6 | 2014 | 43 | |
| 7 | 2016 | 37 | |
| 8 | 2014 | 36 | |
| 9 | 2015 | 35 | |
| 10 | 2015 | 34 | |
| 11 | 2015 | 32 | |
| 12 | 2014 | 32 | |
| 13 | 2023 | 23 | |
| 14 | 2017 | 22 | |
| 15 | 2017 | 22 | |
| 16 | 2014 | 22 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 19 | |
| 19 | 2019 | 17 | |
| 20 | 2015 | 16 |
About Lechi Ye
Lechi Ye is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer-related molecular mechanisms research (6 papers), Colorectal Cancer Surgical Treatments (5 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Hepatology (354 citations), Cancer Research (511 citations), Oncology (628 citations), Pulmonary and Respiratory Medicine (396 citations) and Molecular Biology (589 citations). Lechi Ye has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Ye Wei, Jianmin Xu, Dexiang Zhu, Li Ren, Xinyu Qin, Qing‐Hai Ye, Juji Dai, Tianshu Liu, Wei Cen and Junjun Qiu. Their work appears in journals such as PLoS ONE, Tumor Biology, Annals of Surgical Oncology, Journal of Clinical Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.